LANCASTER, PA — Fulton Financial Corporation (NASDAQ: FULT) reported record third-quarter operating net income of $101.3 ...
While in general, it's better to start investing at low prices, the best time to get started is whenever you can. As long as you invest consistently and over a long period, you'll be able to ride out ...
Safety: ARV-102 was generally well tolerated at single doses up to 200 mg and multiple daily doses up to 80 mg, with no discontinuations due to adverse events (AEs) or serious adverse events (SAEs) ...
Lassonde is building a $200 million juice plant in Upper Deerfield Township, promising fresh juices and jobs, while boosting ...
In this article, we narrow the list into seven best cryptocurrency trading courses, each offering a unique product and the ...
With inflation rising, your money needs to grow faster to keep pace with living costs. To build real wealth, make your money ...
ERNA-101 is based on Ernexa’s technology that engineers induced pluripotent stem cells into induced mesenchymal stem cells (iMSCs), which have a unique ability to migrate toward tumors. The therapy is ...
The clinical-stage biopharmaceutical company reported that 100% of patients achieved clinically meaningful responses in the trial’s co-primary endpoints, with mean reductions of 8.0 points in the ...
Following the positive results from a Phase 2 study (BOOSTB4), BOOST Pharma is now preparing for a pivotal Phase 3 trial of BT-101. In the BOOSTB4 trial, BT-101 was found to be safe and well-tolerated ...
Bonds: Theyre often known as the boring part of a portfolio, but they serve a critical purpose in helping investors manage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results